CD14 and CD44s Expression in Patients with Non-Small Cell Lung Cancer

Basit Öğe Kaydı
dc.contributor.authorAtinkaya, Cansel
dc.contributor.authorBilgic, Emre
dc.contributor.authorYazici, Ulku
dc.contributor.authorTaspinar, Mehmet
dc.contributor.authorOz, Gurhan
dc.contributor.authorYuruker, Sinan
dc.contributor.authorTastepe, Abdullah Irfan
dc.date.accessioned2020-06-25T17:51:46Z
dc.date.available2020-06-25T17:51:46Z
dc.date.issued2011
dc.departmentKırıkkale Üniversitesi
dc.descriptionOzpolat, Berkant/0000-0002-6203-7306; ATINKAYA, CANSEL/0000-0002-8583-3479;
dc.description.abstractObjective: Lung cancer is one of the most common cancers with high mortality. Only 10-15% of the patients with lung cancer survive more than five years despite advanced treatment strategies. Features of tumor immunity are important in carcinogenesis, and immunological mechanisms must be clarified. The role of CD14 and CD44s proteins in tumor immunity of lung cancer is controversial, and studies on these proteins mostly were held on cancer cell lines. In this study, we aimed to investigate CD14 and CD44s protein expressions in tumor and normal tissues in patients with non-small cell lung cancer. Material and Methods: Thirty patients (25 males and 5 females) with non-small cell lung cancer were included in this study. Specimens obtained during the surgery were frozen in liquid nitrogen, and sliced with a thickness of 5 pm using a microtome. Standard immunohistochemical procedures were used for staining and visualization. Differences in staining patterns between normal and tumor tissues were analyzed statistically with Chi-square test.Results: CD14 and CD44s protein expressions were found both in tumor and in the normal tissues. There was no statistically significant difference in staining patterns between normal and tumor tissues (p>0.05).Conclusion: The expression of the two molecules in both tumoral and healthy tissues demonstrates that different pathways of tumor immunity affect the prognosis of the patients. However, further studies are needed in different types of cancers with larger numbers of cases and different antibodies are needed to clarify the role of CD14 and CD44s.en_US
dc.identifier.citationAtinkaya, Cansel & Bilgiç, Emre & Yazici, ülkü & Taspinar, Mehmet & öz, Gürhan & ürüker, Sinan & Ozpolat, Berkant & Taştepe, Abdullah. (2011). CD14 and CD44s Expression in Patients with Non-Small Cell Lung Cancer. Turkiye Klinikleri Journal of Medical Sciences. 31. 518-524.en_US
dc.identifier.doi10.5336/medsci.2010-16943
dc.identifier.endpage524en_US
dc.identifier.issn1300-0292
dc.identifier.issn2146-9040
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-80051762140
dc.identifier.scopusqualityQ4
dc.identifier.startpage518en_US
dc.identifier.urihttps://doi.org/10.5336/medsci.2010-16943
dc.identifier.urihttps://hdl.handle.net/20.500.12587/4984
dc.identifier.volume31en_US
dc.identifier.wosWOS:000293108900002
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isotr
dc.publisherOrtadogu Ad Pres & Publ Coen_US
dc.relation.ispartofTurkiye Klinikleri Tip Bilimleri Dergisi
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCD44 protein, humanen_US
dc.subjectantigens, CD14en_US
dc.subjectcarcinoma, non-small-cell lungen_US
dc.titleCD14 and CD44s Expression in Patients with Non-Small Cell Lung Canceren_US
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
CD14 and CD44s Expression in Patients with Non-Small Cell Lung Cancer.pdf
Boyut:
291.21 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin/Full Text
İndir

Koleksiyon

WOS İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu